Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00003035 · ClinicalTrials.gov registry record · Phase 2

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

A Phase 2 study of Breast Cancer, sponsored by Georgetown University.

Completed
Registry status
Phase 2
Development phase
40
Enrollment target
1
Study location

NCT00003035 is a Phase 2 study of Breast Cancer that has completed, run by Georgetown University. The registered enrollment target is 40 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00003035, a Phase 2 study of Breast Cancer, has completed, sponsored by Georgetown University.

COMPLETED
Registry status
Phase 2
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different ways may kill more tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of doxorubicin with paclitaxel in treating women who have locally advanced breast cancer.

Conditions Studied

Breast Cancer

Interventions

  • DRUG paclitaxel
  • BIOLOGICAL filgrastim
  • DRUG doxorubicin hydrochloride
  • DRUG tamoxifen citrate
  • PROCEDURE surgical procedure

Study Locations (1)

District of Columbia

  • Lombardi Cancer Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 1997-03
Est. Completion 2001-06
Phase Phase 2

Sponsor

Georgetown University

227 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00003035

The ClinicalTrials.gov registry entry for NCT00003035 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which paclitaxel is the first listed.

NCT00003035 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00003035 about?

NCT00003035 is a clinical study titled "Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different ways may kill more tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of doxorubicin with ...

What is the current status of trial NCT00003035?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 1997-03. Estimated completion is 2001-06.

What conditions does trial NCT00003035 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00003035?

The interventions under investigation include: paclitaxel (DRUG), filgrastim (BIOLOGICAL), doxorubicin hydrochloride (DRUG), tamoxifen citrate (DRUG), surgical procedure (PROCEDURE).

Who is sponsoring clinical trial NCT00003035?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00003035 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.